Newly Diagnosed ITP in a Patient With Diabetes and Severe Osteoporosis
A 74-year-old woman is diagnosed with primary immune thrombocytopenia after an isolated platelet count of 21 x 10^9/L on two occasions, with petechiae on her shins and gum bleeding when brushing her teeth. She has no lymphadenopathy, no hepatosplenomegaly, and otherwise normal blood counts. Comorbidities: type 2 diabetes (A1c 8.6% on metformin and glipizide), severe osteoporosis (T-score -3.2 with a prior vertebral compression fracture), hypertension, and stage 3a CKD. She takes aspirin 81 mg daily for primary prevention and omeprazole. She is on no anticoagulants. She has a dental extraction scheduled in 3 weeks and asks whether she should get a platelet transfusion beforehand.
1. Select her initial ITP therapy and justify it against her specific comorbidities; state what you would stop today.
Read the worked answer
She meets a treatment threshold (platelets <30 x 10^9/L with mucosal bleeding), so observation alone is not appropriate.
Option comparison:
- Corticosteroids are guideline-endorsed first line (prednisone 1 mg/kg/day, or dexamethasone 40 mg x 4 days). But an A1c of 8.6%, sulfonylurea therapy, and a T-score of -3.2 with a prior fragility fracture make even a short steroid course relatively unattractive; a prolonged prednisone course would be harmful.
- TPO receptor agonists (eltrombopag 50 mg PO daily, romiplostim 1 mcg/kg SC weekly, or avatrombopag 20 mg PO daily with food) are increasingly used first line, especially when steroids are undesirable, and produce durable platelet responses rather than a transient burst.
- IVIG raises platelets in 1-3 days but the effect lasts only 2-4 weeks - useful as a bridge, not as definitive therapy.
My choice: start a TPO-RA now (eltrombopag 50 mg daily, or 25 mg if East Asian ancestry or hepatic impairment), with weekly CBC titration to a target of 50-100 x 10^9/L. Hold steroids in reserve for a symptomatic crisis. If a rapid rise is needed before the extraction, add a one-time IVIG 1 g/kg rather than committing to weeks of prednisone.
Stop today: aspirin 81 mg (primary prevention - the bleeding risk now clearly outweighs the cardiovascular benefit), any NSAIDs, and intramuscular injections. Continue omeprazole as needed for GI protection.
2. How do you answer her question about platelet transfusion before the dental extraction?
Read the worked answer
Prophylactic platelet transfusion is not the right tool in ITP.
- Transfused platelets are destroyed by the same autoantibody; survival may be minutes to hours. Transfusion is reserved for life-threatening bleeding (intracranial, GI, airway) and even then should be given together with IVIG +/- high-dose steroids so the transfused platelets have any chance of circulating.
- For a simple dental extraction, a platelet count of roughly >=20-30 x 10^9/L is generally sufficient when local hemostatic measures are used: tranexamic acid 4.8% mouthwash four times daily for several days, pressure packs, sutures, atraumatic technique, avoidance of NSAIDs, and morning scheduling with the dentist aware of the diagnosis.
- If her count is still under that range at the time of the procedure, give IVIG 1 g/kg (or 0.4 g/kg/day x 5 days) +/- a short dexamethasone course, then recheck in 24-48 hours; reserve platelet transfusion for uncontrolled bleeding.
- For more invasive surgery, target a higher count (often >=50 x 10^9/L) and coordinate timing with the TPO-RA response.
Practical script: 'We will not give you platelets as a precaution - your body would clear them almost immediately. Instead we will time the extraction for when your count is safe and use a medicated mouthwash and local measures.'
3. Write the monitoring and safety plan for the agent you chose, including what would make you change course.
Read the worked answer
For eltrombopag (or the chosen TPO-RA):
- CBC weekly during dose titration until platelets are stable in the 50-100 x 10^9/L range, then monthly. Do not chase a normal platelet count - the target is a safe count, not a normal one, because thrombotic risk rises with higher counts.
- LFTs at baseline and every 2 weeks during dose adjustment (boxed warning for hepatotoxicity); stop for ALT >=3x ULN with symptoms or >=5x ULN asymptomatic, and re-evaluate.
- Administration counseling: eltrombopag chelates polyvalent cations - separate by 4 hours from calcium, iron, magnesium, aluminum (including antacids and dairy-containing supplements), and take on an empty stomach. Romiplostim is weekly SC and has no dietary restriction; avatrombopag is taken with food, which matters for an older patient with polypharmacy.
- Thrombosis vigilance: counsel on leg swelling, chest pain, sudden dyspnea, headache; she has cardiovascular risk factors. Do not combine with aspirin unless a clear secondary-prevention indication emerges.
- Cataract monitoring (eltrombopag) with a baseline eye exam.
Change course if: platelets remain <30 x 10^9/L after 2-4 weeks at maximum dose, she has clinically significant bleeding, or she develops a thrombotic event. Then reassess the diagnosis (peripheral smear, HIV/HCV, H. pylori testing if not done), consider rituximab or splenectomy, and re-examine whether a second agent (e.g., low-dose eltrombopag plus rituximab) is appropriate.